Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ottawa Heart Institute Research Corporation is the not-for-profit research corporation affiliated with the University of Ottawa Heart Institute, focused on cardiovascular research that spans basic science, translational medicine, observational studies, and clinical trials. The organization supports and administers research funding, infrastructure, and study operations for investigators working across prevention, diagnosis, treatment, and outcomes in heart disease. Its work covers a broad mix of interventions including drugs, devices, imaging, procedures, and behavior-based approaches rather than a single proprietary therapeutic pipeline. OHIRC operates within one of Canada’s leading heart health centres and helps translate bench-to-bedside discoveries into clinical practice. For biotech and healthcare analysts, it is best understood as an active academic clinical research entity and research administration vehicle rather than a venture-backed drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ottawa Heart Institute Research Corporation.